Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +0.39% | +4.51% | +20.57% |
04:13pm | Goldman Sachs Raises Price Target on Merck & Company to $144 From $139 | MT |
03:14pm | Leerink Partners Raises Price Target on Merck & Company to $136 From $132 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.57% | 331B | |
+25.69% | 653B | |
+26.30% | 556B | |
-6.36% | 354B | |
+4.58% | 296B | |
+12.49% | 233B | |
+5.53% | 201B | |
-9.69% | 193B | |
-5.94% | 144B | |
-11.74% | 143B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck : Says Phase 3 Trial Met Endpoints of Overall Survival, Progression-Free Survival in Patients With Cervical Cancer